IO Biotech Inc (IOBT)
1.34
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
IO Biotech Cash from Financing (TTM): 71.86M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 71.86M |
December 31, 2023 | 71.86M |
September 30, 2023 | 71.87M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 187.54M |
June 30, 2022 | 187.54M |
March 31, 2022 | 187.54M |
December 31, 2021 | 252.95M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
Dec 2022
252.95M
Maximum
Dec 2021
103.12M
Average
71.86M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 14.71M |
iBio Inc | 14.24M |
Theriva Biologics Inc | 0.68M |
Oragenics Inc | 2.096M |